PMC:7048180 / 10536-10748 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T52","span":{"begin":191,"end":211},"obj":"Disease"}],"attributes":[{"id":"A52","pred":"mondo_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"These results suggest that CR3022 has the potential to be developed as candidate therapeutics, alone or in combination with other neutralizing antibodies, for the prevention and treatment of 2019-nCoV infections."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T70","span":{"begin":34,"end":37},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"These results suggest that CR3022 has the potential to be developed as candidate therapeutics, alone or in combination with other neutralizing antibodies, for the prevention and treatment of 2019-nCoV infections."}

{"project":"LitCovid-sentences","denotations":[{"id":"T64","span":{"begin":0,"end":212},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These results suggest that CR3022 has the potential to be developed as candidate therapeutics, alone or in combination with other neutralizing antibodies, for the prevention and treatment of 2019-nCoV infections."}

{"project":"LitCovid-PubTator","denotations":[{"id":"374","span":{"begin":27,"end":33},"obj":"Chemical"},{"id":"375","span":{"begin":191,"end":211},"obj":"Disease"}],"attributes":[{"id":"A375","pred":"tao:has_database_id","subj":"375","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"These results suggest that CR3022 has the potential to be developed as candidate therapeutics, alone or in combination with other neutralizing antibodies, for the prevention and treatment of 2019-nCoV infections."}